• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Substituted C19 steroid analogs as inhibitors of aromatase.

作者信息

Brueggemeier R W, Snider C E, Counsell R E

出版信息

Cancer Res. 1982 Aug;42(8 Suppl):3334s-3337s.

PMID:7083196
Abstract

Various C19-steroidal derivatives have been synthesized and evaluated in biochemical assays for their ability to inhibit the biosynthesis of estrogens. Steroids with substitutions on the A or B ring were prepared by Michael addition of various thiol reagents to appropriate dienone intermediates. An in vitro assay using human placental microsomes was used to evaluate aromatase-inhibitory properties. Synthesized compounds that exhibited high inhibitory activity were further evaluated under initial velocity conditions to determine apparent Ki values. Several 7 alpha-substituted androstenediones were effective competitive inhibitors and have apparent Ki values ranging from 18 to 69 nM, with the apparent Km for androstenedione being 63 nM. The most effective competitive inhibitor tested is 7 alpha-(4'-amino)phenylthioandrost-4-ene-3,17-dione with an apparent Ki of 18 nM. Derivatives of this 7 alpha-thioether compound that contain alkylating moieties have been prepared as potential irreversible enzyme inhibitors and demonstrate varying abilities to inactivate the aromatase enzyme. The results of these studies demonstrate that large chemical functionalities such as an aromatic ring with polar substituents can be accommodated in or near the active site of aromatase and, in some cases, can enhance the affinity of the enzyme for the inhibitors.

摘要

相似文献

1
Substituted C19 steroid analogs as inhibitors of aromatase.
Cancer Res. 1982 Aug;42(8 Suppl):3334s-3337s.
2
Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
J Med Chem. 1978 Oct;21(10):1007-11. doi: 10.1021/jm00208a002.
3
Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.7α-取代雄烯二酮作为芳香化酶抑制剂的生物化学与药理学
J Steroid Biochem Mol Biol. 1997 Apr;61(3-6):247-54.
4
Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.6-取代雄甾-4-烯类似物作为芳香酶抑制剂的合成及其构效关系
J Med Chem. 1996 May 24;39(11):2245-52. doi: 10.1021/jm960047o.
5
A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.基于自杀底物抑制剂研究提出的关于芳香化酶作用机制的新假说。
Cancer Res. 1982 Aug;42(8 Suppl):3327s-3333s.
6
A photoaffinity inhibitor of aromatase.
Steroids. 1982 Dec;40(6):679-89. doi: 10.1016/0039-128x(82)90009-5.
7
6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromatase.
J Med Chem. 1997 Sep 26;40(20):3263-70. doi: 10.1021/jm970325z.
8
Aromatase inhibition by 4-thiosubstituted-4-androstene-3,17-dione derivatives.
J Steroid Biochem. 1990 Jan;35(1):139-43. doi: 10.1016/0022-4731(90)90158-o.
9
Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.芳香化酶催化作用参与了由4-乙酰氧基-和4-羟基-4-雄烯-3,17-二酮引起的雌激素生物合成的有效抑制过程。
Mol Pharmacol. 1982 Jan;21(1):173-80.
10
6beta,19-Bridged androstenedione analogs as aromatase inhibitors.作为芳香酶抑制剂的6β,19-桥连雄烯二酮类似物
Steroids. 2009 Nov;74(12):884-9. doi: 10.1016/j.steroids.2009.06.001. Epub 2009 Jun 12.

引用本文的文献

1
Electronic transitions and heterogeneity of the bacteriophytochrome Pr absorption band: An angle balanced polarization resolved femtosecond VIS pump-IR probe study.电子跃迁和菌视黄质 Pr 吸收带的非均一性:角平衡偏振分辨飞秒可见泵浦-红外探测研究。
Biophys J. 2013 Oct 15;105(8):1756-66. doi: 10.1016/j.bpj.2013.08.041.
2
Aromatase inhibitors--mechanisms of steroidal inhibitors.芳香化酶抑制剂——甾体类抑制剂的作用机制
Breast Cancer Res Treat. 1994;30(1):31-42. doi: 10.1007/BF00682739.